Month: September 2025

he European Commission’s Research and Innovation Directorate-General organised a Reality Check on implementation aspects of Horizon Europe, the EU’s research and innovation Framework Programme, as part of the Commission’s approach to better implementation and simplification.
It focused on practical experience with Horizon Europe, aiming to collect feedback on implementation from external stakeholders and identify opportunities for simplification.
Dr. Anna Sandak was among 5 panellists. She emphasized EIC portfolio approach and EIC business acceleration services, training, and coaching. However, she also pointed out current challenges the project calls are facing and suggested possible improvements.
Besides her other researchers and innovators with extensive experience across the three main pillars of Horizon Europe shared their experiences with several Horizon Europe projects.
The event brought together more than 800 participants offering a valuable platform for discussion and exchange of ideas.
Watch here the video of the event and learn more about the Horizon Europe projects.

Project REMEDY (Archibiome tattoo for resistant, responsive, and resilient cities), coordinated by Dr. Anna Sandak, InnoRenew CoE, UP IAM researcher, was featured in the newly published EU-IN Horizon Scanning Report – Engineered living materials for in situ production of therapeutics by the European Medicines Agency.

The project was presented as one of the relevant examples from the ongoing EIC Pathfinder Challenge on Engineered Living Materials (ELMs), launched by the European Innovation Council (EIC).

The REMEDY project aims to develop an archibione tattoo that uses living microbes for functional decoration, biotherapeutic effects and sustainability benefits such as carbon sequestration and bioremediation. Remedy brings life to materials.

You can read the recently published report here: Engineered living materials for in situ production of therapeutics

You can read more about the Remedy project here: https://eic-remedy.eu/?lang=en&pagename=home

The REMEDY project, funded by the European Union’s Horizon Europe programme (European Innovation Council), held its 1st progress meeting.

All project partners gathered online to discuss key project activities of each work package, discuss common challenges and plan for the project’s next tasks. Additionally, the financial aspects and reporting was presented.

The project REMEDY aims to achieve a breakthrough in fundamental research in microbiology and synthetic biology, transfer the know-how to materials science in the form of engineered living materials, and develop compatible biofabrication processes that allow personalised design in the architectural context.

For more information about REMEDY, visit the LinkedIn profile.